Shanghai Qinyi Investment

Shanghai Qinyi Investment

Shanghai Qinyi Investment was founded by Li Bin, who previously served as an Executive Director of Yestar Healthcare, a publicly listed medical distribution and services company in Asia. His long-standing business association with James Hartono, Yestar's Chairman and CEO, shapes the firm's network and likely deal flow. Family members Liu Hong and Li Yue are also involved in related business acquisitions and shareholdings, pointing to a family-oriented investment structure. The firm operates as a generalist venture investor, spanning early-stage seed and start-up rounds through to expansion and late-stage deals. This multi-stage mandate allows it to follow companies from inception to growth, a posture often anchored by deep sector expertise from the founding team. While specific portfolio companies are not publicly named, the connection to Yestar Healthcare suggests a strong competence in healthcare services, medical devices, and related Asia-Pacific distribution networks. The geographic focus remains centered on China, with potential opportunistic exposure across the broader Asian market. Li Bin operates the firm alongside a Shanghai-based marketing center, indicating a compact team structure typical of principal-led investment offices. The firm has not disclosed total deployment figures or assets under management. No external vehicles, co-investor clubs, or philanthropic foundations are publicly linked to the entity, suggesting it operates as a lean, direct-investment vehicle for its founder and close associates. The firm's defining architecture is its deep integration with a single, successful operating company — Yestar Healthcare. Unlike a traditional family office that monetizes a liquidity event and then allocates broadly, Shanghai Qinyi appears to have grown out of a long-running executive partnership. This hybrid operator-investor model provides a specific informational edge in healthcare, even as the firm scans for opportunities across venture stages.